Health Care: Drugs

Impax Laboratories Inc (IPXL: NASDAQ)

$45.74 n/a | n/a%
03/27/15 - 03:59 PM ET
Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 596.05M 511.50M 581.69M 512.92M
Cost of Sales 250.14M 276.86M 210.17M 235.80M
Gross Operating Profit 345.90M 234.65M 371.52M 277.12M
Selling, General, and Administrative Expenses 139.39M 120.29M 118.24M 68.48M
Research & Development 79.11M 68.85M 81.32M 82.70M
Operating Income before D & A (EBITDA) 127.40M 45.50M 171.96M 125.94M
Depreciation & Amortization 33.25M 35.35M 88.96M 18.82M
Interest Income 1.47M 1.30M 1.09M 1.15M
Other Income - Net 313.00K 152.45M -138.00K -2.59M
Special Income / Charges -5.33M -16.54M 0.00 -7.51M
Total Income Before Interest Expenses (EBIT) 90.60M 147.36M 83.94M 98.17M
Interest Expense 43.00K 419.00K 632.00K 157.00K
Pre-Tax Income 90.56M 146.94M 83.31M 98.01M
Income Taxes 33.21M 45.68M 27.44M 32.62M
Minority Interest 0.00 0.00 0.00 -97.00K
Net Income From Continuing Operations 57.35M 101.26M 55.87M 65.40M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 57.35M 101.26M 55.87M 65.40M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 57.35M 101.26M 55.87M 65.50M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
62.69M 117.80M 55.87M 72.90M
Preferred Dividends
Net Income Available To Common 57.35M 101.26M 55.87M 65.40M
Basic EPS from Continuing Ops. 0.84 1.51 0.85 1.02
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 0.84 1.51 0.85 1.02
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 0.84 1.51 0.85 1.02
Basic Normalized Net Income/Share 0.92 1.76 0.85 1.14
EPS fr Continuing Ops. 0.81 1.47 0.82 0.97
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 0.81 1.47 0.82 0.97
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 0.81 1.47 0.82 0.97
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0.89 1.72 0.82 1.08
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with IPXL

Latest IPXL Headlines from TheStreet

More Financial News for IPXL

Press Releases for IPXL

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter